Skip to content
Insider tapeLive · 5:07 PM ET
My stocks

Michael David Garrison

At a glance: Michael David Garrison is Evp & Pres Med.Essntl&Biopharm at Becton Dickinson (BDX). Their latest SEC Form 4, filed Jun 25, 2026, reported a sale of $160K. On file: 0 purchase lines ($0) and 5 sale lines ($784K).

Disclosed holdings: about $2.8M of BDX stock: 13,172 shares reported on their latest Form 4 (filed Jun 25, 2026), valued at the Nov 20, 2026 close of $214.28. This counts only BDX shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.

Evp & Pres Med.Essntl&Biopharm at Becton Dickinson & Co (BDX)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $784K

Michael David Garrison's InsiderPrint

5 trades from SEC Form 4 filings, 2025 to 2026, drawn as one fingerprint.

InsiderPrint of Michael David Garrison: 5 trades, 2025 to 20262025: 0 buys, 1 sale2026: 0 buys, 4 sales

Reading this print: Almost only sells, trading about 5 times a year, typically $160K a trade; most sales are on a pre-planned 10b5-1 schedule.

  • Bump outward: a purchase (0)
  • Dent inward: a sale (5)
  • One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.

Insiders with a similar print

  1. Keelan AdamsonCEO, President · RIG · 100% match
  2. Erika Ashley FisherGeneral Counsel · HUBS · 100% match
  3. Christopher Michael RyanCOO, President · GEVO · 100% match
  4. Steve PakolaChief Medical Officer · RGNX · 100% match
  5. Mark A. MarinoCFO · RXT · 100% match

Matched on seven traits of each insider's trading pattern (buy share, pace, typical size, planned sales, seasonality, buying after drops, number of companies). Pattern matching on public filings; history, not a prediction.

Reported trades

Filed Stock Type Shares Price Value Since
Jun 25SEC BDXBecton Dickinson & Co Sell Plan 1,10013,172 held (−8%) $145.66 $160K +47.1%
Jun 11SEC BDXBecton Dickinson & Co Sell Plan 1,10014,272 held (−7%) $151.48 $167K +41.5%
Jan 16SEC BDXBecton Dickinson & Co Sell Plan 60013,105 held (−4%) $209.00 $125K +2.5%
Jan 16SEC BDXBecton Dickinson & Co Sell Plan 1,01012,095 held (−8%) $206.54 $209K +3.7%
Dec 17SEC BDXBecton Dickinson & Co Sell Plan 62913,105 held (−5%) $196.03 $123K +9.3%
  • Sell

    Evp & Pres Med.Essntl&Biopharm Michael David Garrison sold $160K of BDX at $145.66 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Evp & Pres Med.Essntl&Biopharm Michael David Garrison sold $167K of BDX at $151.48 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Evp & Pres Med.Essntl&Biopharm Michael David Garrison sold $125K of BDX at $209.00 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Evp & Pres Med.Essntl&Biopharm Michael David Garrison sold $209K of BDX at $206.54 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Evp & Pres Med.Essntl&Biopharm Michael David Garrison sold $123K of BDX at $196.03 — pre-scheduled 10b5-1 plan sale.

Follow Michael David Garrison

Get one email when Michael David Garrison files a new purchase or sale. Free.

At most one email a day about Michael David Garrison, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.